028300.KQ
HLB Co., Ltd.
KOE · Healthcare · Biotechnology · KR
KRW 32,800.00
−1.65%Margins
Gross margin
38.4%
EBITDA margin
-93.8%
EBIT margin
-95.6%
Net margin
-219.1%
FCF margin
-103.7%
-62.0%
Return on equity
-23.5%
Return on assets
-14.5%
Return on invested capital
0.11x
Asset turnover
-KRW 90.8B
Cash from operations
KRW 427
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026